Slingshot members are tracking this event:
FDA Grants Priority Review for Lilly's Olaratumab, an Investigational Medicine for Advanced Soft Tissue Sarcoma
Slingshot Insights Explained
May 04, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Olaratumab, Advanced Soft Tissue Sarcoma, Breakthrough Therapy, Fast Track, Orphan Drug, Priority Review